Medicus Pharma Ltd. (MDCX)
Nasdaq · Pharmaceutical Preparations · Inc. A6
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Medicus Pharma Ltd.. Most notable: 2026-09-03: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-04 | Bokhari Raza | director | A | 2,941,176 | 0.17 | $501,471 |
| 2026-09-04 | Bonner Carolyn F. | officer | A | 1,470,588 | 0.17 | $250,735 |
| 2026-09-04 | Brennan Edward J. | officer | A | 588,235 | 0.17 | $100,294 |
| 2026-09-04 | Mehmud Faisal | officer | A | 1,470,588 | 0.17 | $250,735 |
| 2026-09-04 | Smith Andrew Alasdair | officer | A | 735,294 | 0.17 | $125,368 |
| 2025-08-13 | Quinlan James P. | officer | M | 125,000 | 0.81 | $101,250 |
| 2025-08-13 | Quinlan James P. | officer | M | 20,000 | 2.75 | $55,000 |
| 2025-05-20 | Melani Kenneth R. | ten percent owner | S | 75,000 | 7.72 | $579,000 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.